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or cardiovascular diseases[2–4] and also for 
regeneration in peripheral arterial disease 
in both animal and human studies.[5,6]
Most current preclinical and clinical 
cell therapy trials consist of local or sys-
temic delivery of stem or progenitor cells, 
and rely on the migration and retention of 
implanted cells at sites of injury.[7] How-
ever, determining the fate and localization 
of these cells inside the body, as well as 
targeting the cells to a particular location, 
are still major challenges. To address these 
concerns, several methods have been 
developed to label therapeutic cells ex vivo 
in order to monitor their fate after in vivo 
administration. Among the different avail-
able modalities, X-ray computed tomog-
raphy (CT),[8] magnetic resonance imaging 
(MRI),[9] positron emission tomography,[10] 
and single photon emission computed tomography[11] have 
been used. However, the detection sensitivity of transplanted 
cells using such techniques is in some cases very low, or ren-
dered difficult and costly by the use of radiopharmaceutical 
compounds. Optical imaging is expected to contribute to the 
development of cell transplantation, as it is less costly, easier 
to handle, nonionizing, and very sensitive.[12] For that purpose, 
various optical labeling techniques have been developed to 
Once injected into a living organism, cells diffuse or migrate around the 
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1. Introduction
In recent years, cells have shown great potential in a number 
of biomedical applications and researches in this area received 
much attention.[1] Cell therapies using mesenchymal stem 
cells (MSC) or endothelial progenitor cells (EPC) have dem-
onstrated significant potential for the treatment and cure of 
several diseases such as cancer, diabetes, neurodegenerative 
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apprehend cell behavior in vitro and in vivo.[13] However, optical 
in vivo detection is impaired by the autofluorescence signal 
coming from the body when exciting the probes.[14] To over-
come this parasitic signal, our group pioneered the use of per-
sistent luminescent nanoparticles (PLNPs) for in vivo imaging. 
Acting as optical capacitors, PLNPs can emit light in the tissue 
transparency window for minutes to hours after the end of an 
UV or visible illumination, leading to signals without autoflu-
orescence and high target to background ratio.[15–20] Recently, 
ultrasensitive detection of labeled cells in small animals either 
after intravenous or subcutaneous injection was demonstrated 
in preliminary studies using PLNPs.[18,21,22]
The long-term efficacy of stem cells therapy is presently 
relatively low, which can be due to a lack of cell retention in 
the treatment area,[23] misplaced-injection, or cell injection 
into highly fibrotic tissues.[24] Fortunately, unproperly local-
ized injection can be prevented by real-time imaging guidance 
to ensure sufficient cell delivery to the desired tissue location. 
In order to improve cell delivery, several reports have shown 
that the in vivo biodistribution of cells labeled with magnetic 
nanoparticles could be influenced by applying a magnetic field 
and gradient.[25,26] Various preclinical studies have exploited the 
magnetic properties acquired by cells carrying magnetic nano-
particles in order to increase the retention of implanted cells at 
specific sites within the body, for example with endothelial cells 
or EPC.[27–29]
Recently, we have developed a modified approach to syn-
thesize a new class of mesoporous nanohybrids (MPNHs) 
consisting of PLNPs and USPIOs incorporated into the same 
mesoporous silica matrix.[30] We thus wondered whether 
these new nanohybrids could be used to label cells of interest 
in order to both control their in vivo fate, using their mag-
netic property, and to follow in real time their distribution, 
using their persistent luminescent property, after injection. 
As a model, we chose a subpopulation of EPC called “late” 
EPC or endothelial colony-forming cells (ECFC) that present 
blood vessel-forming ability.[31,32] Herein, we report the use 
of MPNHs to label ECFC in nontoxic conditions, allowing 
these cells to keep their proliferation ability and biological 
properties. After labeling, it was possible to detect the cells in 
vivo and we show that MPNHs-COOH labeled ECFC can be 
remotely controlled in vivo by applying an external magnetic 
field and gradient.
2. Results and Discussion
2.1. Characterization and Functionalization of the Nanohybrids
We have previously reported the synthesis of different 
MPNH made of PLNPs and containing increasing amount 
of USPIOs (0, 1.4, 3.5, and 5.2% (w/w), named MPNH0, 
MPNH1, MPNH2, and MPNH3, respectively) incorporated 
into a silica matrix (Figure 1a–d). These nanohybrids have 
been synthesized using tetraethoxysilane (TEOS), cetyltri-
methylammonium bromide (CTAB), and comprise the two 
types of nanoparticles (PLNPs and USPIOs).[30] In order 
to evaluate the influence of the nanohybrids surface both 
Small 2018, 1800020
Figure 1. TEM images of nonfunctionalized a) MPNH0, b) MPNH1, c) MPNH2, and d) MPNH3. e) Decay curves of MPNHs after 2 min UV (254 nm) 
or red-LED illumination. Persistent luminescence intensity is expressed in log10 scale in arbitrary units. f) Synthetic pathway from MPNHs-OH to 
MPNHs-COOH. Adapted with permission.[31] Copyright 2007, American Society of Hematology.
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on the internalization efficacy and on the cell cytotoxicity, 
these nanohybrids have been coated either with (3-amino-
propyl)triethoxysilane (APTES) to introduce amine groups 
on the MPNHs (MPNH-NH2) or with diglycolic anhydride 
(DGA) to introduce carboxylic acids functions (MPNH-
COOH) (Figure 1f). The different MPNHs have a spher-
ical-like shape (Figure 1a–d) and persistent luminescence 
properties after both UV and visible excitation (Figure 1e). 
The light emission can persist for several dozen of minutes 
after the end of the excitation, which is necessary to get in 
vivo optical signals without background. Figure 1e also 
informs about the compared efficacy of UV versus visible 
illumination. As shown on the corresponding decay curves, 
the persistent luminescence signal is approximately one log 
weaker following visible light excitation, in comparison with 
the signal obtained following UV excitation. Such typical 
trend regarding the persistent luminescence signal of these 
MPNHs matches the results demonstrated earlier in several 
other studies from our group.[30,33] More importantly, the per-
sistent luminescence properties of MPNHs do not vary with 
the percentage of USPIO (Figure 1e). As expected, the func-
tionalization procedure has an effect on the zeta potential of 
the MPNHs: MPNHs-NH2, with the amino groups, are proto-
nated in mQ water and have positive surface charges, whereas 
MPNHs-COOH, with the carboxylic acids, have negative zeta 
potentials (Table 1). In addition, the amount of USPIOs does 
not seem to have any major impact on the global physico-
chemical properties of the MPNHs. Notably, all MPNHs dis-
play both similar zeta potential, either positive around +40 mV 
with MPNHs-NH2 or negative around −40 mV with MPNHs-
COOH, and hydrodynamic diameters which are rather stable 
around 190 nm from MPNH0-COOH to MPNH3-COOH.
2.2. In Vitro Cell Labeling and Toxicity Assays
As a cell model we have chosen ECFC, a variety of endothe-
lial progenitors.[31,32] Thus, our objective was to find nontoxic 
conditions to label ECFC with MPNH and allow in vivo cell 
tracking under magnetic control.
We first assessed the influence of three parameters designated 
as the type of MPNH, the surface coating (NH2 or COOH) 
and the incubation time (6 and 24 h) on the global ECFCs 
viability. To this end, 10 000 cells deposited in 96-well plates 
were incubated with increasing amounts of nanoparticles. The 
Alamar blue test was used to evaluate the cell metabolic activity. 
As can be observed in Figure 2, the coating has an influence 
on cell viability. When we look at MPNH0 (nanohybrids with 
0% of USPIOs), we can verify that amine-coated MPNHs are 
more cytotoxic than the carboxylic coated ones (Figure 2a). This 
is certainly due to the positive charge of amine-coated MPNHs, 
leading to a higher cellular uptake as can be seen in the litera-
ture.[34,35] This apparent toxicity is even more important when 
the incubation time increases from 6 to 24 h. In contrast to par-
ticle coating, the amount of USPIOs in MPNH type (MPNH1–3) 
has little influence on the cell viability (Figure 2a–d). Such 
absence of effect could be attributed to the fact that USPIOs 
are incorporated into the core of the silica matrix, therefore not 
in direct contact with the cells. Moreover, this trend is also in 
line with previous work in which USPIOs alone are not respon-
sible for any significant cytotoxic effect at these concentrations 
(<1 × 10−3 m) on endothelial cells.[36,37] Finally, we observed that 
the low cytotoxicity of MPNHs-COOH is time independent.
Beside the assessment of cellular metabolic activity by 
Alamar blue test, a cell proliferation assay was carried out up 
to 7 days postlabeling. For this purpose, we selected a concen-
tration of MPNHs for which the cell viability with the Alamar 
blue test was above 80% at 24 h, i.e., 0.25 mg mL−1 (which cor-
respond to 73.5 µg of MPNH per cm2). As can be seen from 
Figure 2e, exposure of ECFC to MPNH3-NH2 appears to sig-
nificantly alter the proliferation, as compared to a control group 
(CT). These results are consistent with our previous observa-
tion using the Alamar blue test. On the other hand, incubation 
of ECFC with MPNH3-COOH does not alter the proliferation of 
ECFC even after 7 days of proliferation (Figure 2e).
2.3. Cellular Uptake of Nanohybrids and Optomagnetic 
Properties of Labeled Cells
To determine the cell uptake of the MPNHs, different tech-
niques have been used. Since the MPNHs-COOH are less 
cytotoxic, a concentration of 73.5 µg cm−2 (0.25 mg mL−1) for 
each MPNH-COOH was chosen for subsequent experiments. 
Transmission electron microscopy (TEM) observations of ECFC 
(6 h after labeling) principally show intraendosomal confine-
ment of the different MPNH1–3-COOH (Figure 3a–c), thus 
indicating that the low toxicity obtained by Alamar blue and 
proliferation tests are not the consequence of an absence of 
MPNHs-COOH internalization. We can also observe that these 
nanoparticles are internalized in different ways: some MPNHs 
are observed in small intracellular vesicles, while the majority 
are clustered in large lysosome-like vesicles. MPNHs isolated in 
small vesicles probably follow clathrin-dependent endocytosis, 
as previously shown with silica nanoparticles of about one hun-
dred nanometers.[38]
In order to quantify the amount of MPNHs internalized 
by the cells, a magnetophoresis experiment was performed 
with cells labeled under conditions identical to that of the 
TEM experiment. By exploiting the magnetophoretic mobility 
of each labeled cell in suspension in a magnetic field gra-
dient, we were able to determine the mass of iron per cell, 
deduced from the measurements of single cell velocity toward 
the magnet and cell radius (Figure 3d).[39] Depending on 
the initial amount of USPIOs in MPNHs, the average mass 
Small 2018, 1800020
Table 1. DLS measurements giving hydrodynamic diameters and 
ζ-potentials of MPNHs-NH2 and MPNHs-COOH.
Potential ζ  
[mV]
Hydrodynamic 
diameter [nm]/
polydispersity 
index
Potential ζ  
[mV]
MPNH0-NH2 36.2 ± 1,9 MPNH0-COOH 200/0.024 −44.7 ± 2.1
MPNH1-NH2 38.3 ± 0,9 MPNH1-COOH 185/0.046 −42.2 ± 2.1
MPNH2-NH2 46.3 ± 2,4 MPNH2-COOH 191/0.050 −39.2 ± 2.2
MPNH3-NH2 35.7 ± 2,7 MPNH3-COOH 186/0.052 −40.0 ± 2.6
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of iron per cell approximately varies from 1.7 to 3 pg. These 
results are consistent with previous studies reporting EPC 
labeling with similar USPIOs, which obtained iron load from 
3[27] to 10[36] pg per cell after incubation with iron concentra-
tions of 0.1 or 5 × 10−3 m. In our case, we used lower iron 
concentrations ranging from 0.043 to 0.16 × 10−3 m (for 
0.25 mg mL−1 of MPNH1 and MPNH3, respectively) and 
USPIO were embedded in the silica matrix. In addition to the 
mean cellular magnetic load, this assay allows determining 
the iron mass distribution in the cell population (Figure S1, 
Supporting Information). As MPNHs compositions were pre-
viously determined using ICP-MS,[30] we could determine the 
average mass of MPNHs per cell from the magnetophoresis 
data (Figure 3e). Unexpectedly, the data from Figure 3e 
indicate that the final amount of MPNHs per cell depends on 
the type of MPNHs. Indeed, the higher the USPIOs load in 
MPNHs, the lower the MPNHs uptake within each cell. Cells 
labeled with MPNH2-COOH contain the same amount of 
iron as those labeled with MPNH3-COOH (Figure 3d). Thus, 
MPNH3 are less internalized than MPNH2 and MPNH1.
After the magnetophoresis experiments, the cells were 
embedded in an agarose gel (1.5.106 cells per mL) to be charac-
terized by MRI spectrometry in order to measure both T1 and 
T2 relaxation times (Figure 3f; Figure S2, Supporting Informa-
tion). The presence of USPIOs in cells shows a slight but non-
significant influence on T1-weighted images, and no difference 
between the T1 of the gel containing the nonmagnetic MPNH0-
COOH labeled ECFC when compared to the control (Figure S2, 
Small 2018, 1800020
Figure 2. Cytotoxicity of MPNHs in ECFC. a–d) Percentage of viability after 6 (red and blue diamonds) or 24 h (black squares) of incubation with MPNHs-NH2 
(red curves) or MPNHs-COOH (blue curves). All types of MPNH (MPNH0 to MPNH3, as shown on graphs (a) to (d), respectively) were tested for 
concentrations from 31.25 µg mL−1 (9.19 µg cm−2) to 1 mg mL−1 (294 µg cm−2). e) Cell proliferation after incubation in the absence (control, blue 
diamonds) or presence of MPNH3-NH2 (red squares) or COOH (green squares) (incubation time 6 h, concentration of 0.25 mg mL−1/73.5 µg cm−2). 
Proliferation capacity was not affected by the carboxylic coating, as opposed to the amino coating, compared with growth capacity in control.
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Supporting Information). As expected from magnetically 
labeled cells, the contrast evolution is much more important 
when looking at T2-weighted images.[40] The gel containing the 
nonmagnetic MPNH0-COOH labeled cells (dark blue column) 
displayed a contrast similar to the control gel containing unla-
beled ECFC (light blue column), but the gels containing cells 
labeled with magnetic MPNH1,2,3 have a much lower T2 than 
the control (Figure 3f).
Due to the dual imaging properties of PLNPs, the labeled 
cells can be readily detected through their luminescence emis-
sion. We compared the luminescence intensity of cells labeled 
with the four MPNHs under the same conditions. The gels 
previously used for the MRI experiment were illuminated 
with a visible light emitting diode (LED) and the persistent 
luminescence was measured (Figure 3g). After visible illumi-
nation, the luminescence of the labeled cells clearly depends 
on the type of MPNH used. The more USPIO concentration 
in MPNHs, the lower is the cell luminescence. These varia-
tions in the luminescence emission are well correlated to the 
different cellular uptake reported before (Figure 3e). While 
MPNH3-COOH labeled cell has similar iron content and mag-
netophoretic mobility compared to MPNH2-COOH labeled cell, 
their luminescence is six times lower than those labeled with 
MPNH2-COOH (Figure 3g) which is in line with the different 
cell uptake. In addition, despite the higher luminescence inten-
sity of MPNH1-COOH labeled cells, their magnetic resonance 
detectability and magnetic attraction are very low compared to 
MPNH2-COOH labeled cells. Therefore, in a trade-off between 
cellular uptake, luminescence detection, MR detection, and 
magnetophoretic mobility of cells, MPNH2-COOH appears as 
the best candidate to carry out further in vivo dual image-guided 
and magnetically targeted cellular vectorization experiment.
2.4. Functional Properties of Labeled Cells
For in vivo cell-based therapy, labeled progenitor cells should 
maintain crucial biological properties such as migration and 
capillary network formation abilities.[37,41–43] Thus, we per-
formed two sets of experiments to evaluate these properties. In 
vitro, the study of cell migration was carried out using a wound 
healing assay.[44] We created a wound gap in a MPNH-labeled 
ECFC monolayer by scratching and monitored their migra-
tion toward the gap. The remaining gaps in MPNH-treated 
wells were measured when control scratches had disappeared, 
around 24 h after their realization. Thus, injured areas were 
photographed to assess healing in each area. Figure 4a shows 
the initial injuries (t0) and 24 h later (24 h). The wounds are 
Small 2018, 1800020
Figure 3. Optical and magnetic characterizations of MPNHs labeled ECFC. a–c) Electron microcope images of ECFC after 6 h of incubation with 
a) MPNH1-COOH, b) MPNH2-COOH, and c) MPNH3-COOH (0.25 mg mL−1/73.5 µg cm−2). d) Fe and e) MPNH1,2,3-COOH mean load per cell after 
incubation. Statistical analyses were realized using an Anova test followed by a Bonferroni comparison. Bar graphs show mean ± SEM (n = 88, 178, 
and 109 for MPNH1, MPNH2, and MPNH3, respectively). ** and *** correspond to p < 0.01 and 0.001, respectively. f) T2 MRI measurements and 
images of agarose gels with 1.5.106 ECFC mL−1. Control tube (CT, sky blue) contains the same concentration of unlabeled ECFC. Bar graph shows 
mean ± SD, images of corresponding tubes are shown under the graphics. g) Persistent luminescence of previously described agarose gels after 5 min 
of red-LED illumination (bar graph shows mean ± SD).
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almost all closed after 24 h. Compared to the untreated con-
trol, only cells treated with MPNH1-COOH showed significant 
decrease in the cell ability to close up the gap (Figure 4f,k). How-
ever, according to magnetophoresis results, MPNH1-COOH are 
the most internalized nanoparticles by ECFC among USPIOs 
containing MPNH. It is then conceivable that the greater inter-
nalization of MPNH1-COOH is responsible for the longer gap 
closing delay. It is worthwhile to precise that these results were 
obtained when cells were cultured in EGM-2 culture medium 
with 2% (v/v) of fetal calf serum. This is necessary to avoid a 
bias due to cell proliferation: a control with 10% (v/v) of fetal 
calf serum showed no difference in the wound healing between 
control and labeled ECFC (data not shown).
As previously mentioned, ECFC have been shown to pos-
sess all the characteristics of endothelial progenitors to promote 
vascular repair and angiogenesis in vivo.[31,32] Evaluating their 
ability to form vascular structures is one of the most specific 
ways to assess their ability to stimulate angiogenesis. This was 
tested in vitro by plating cells on constituents mimicking the 
extracellular matrix called Matrigel. Matrigel stimulates the 
organization of endothelial cells in networks evoking micro-
vasculature. ECFC were labeled with MPNHs-COOH before 
seeding on Matrigel for 16 h. Under these experimental con-
ditions, labeled and control ECFC formed extensive tubular 
network and the labeling process did not affect their properties 
(Figure 5; Figure S3, Supporting Information). Typical charac-
terizations of tubular structures include the total number of 
tubes and their mean lengths (Figure 5f,g, respectively), but it is 
also possible to evaluate the mean covered area, the number of 
loops, the total length of the network, the loops mean areas and 
perimeters, as well as the total branching points (Figure S3a–f, 
respectively). As can be seen on the Figure 5 and Figure S3 
(Supporting Information), there is no significant difference 
between the networks formed by labeled and non-labeled ECFC, 
regardless of the property under consideration. Similar results 
have already been reported in the literature using magnetic 
nanoparticles.[36] Altogether, these results confirm the MPNHs 
innocuousness regarding ECFC proangiogenesis properties.
2.5. Real-Time Dynamic Tracking and Magnetic Manipulation of 
Transplanted Cells In Vivo
As a proof of concept, we carried out in vivo experiment to 
determine whether it was possible to follow the distribution of 
MPNH-labeled ECFC in real time by luminescence imaging 
and simultaneously to control their localization by magnetic 
fields. ECFC were labeled with MPNH0-COOH or MPNH2-
Small 2018, 1800020
Figure 4. Assessment of the invasion ability of labeled ECFC. a–j) Images of wounds were taken 24 h after their realization, when control wounds had 
disappeared. k) Evaluation of invasion latency between control and labeled ECFC. Statistical analyses were realized using an Anova test followed by a 
Bonferroni comparison. Bar graphs show mean bar graph, which shows mean ± SD, * indicates p < 0.05.
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COOH under the same conditions to those previously used. 
5.105 labeled ECFC were preilluminated by an orange LED for 
5 min and were then injected in the peritoneal cavity of BALB/c 
mice. A luminescence image was acquired before and after 
applying a magnet to the right side of each mouse. The ECFC 
labeled with MPNH0-COOH represent the control group since 
MPNH0 do not contain USPIOs and therefore do not react to 
the presence of a magnetic field gradient. To evaluate the influ-
ence of the presence of an external magnet on the distribution 
of ECFC, we monitored the persistent luminescence intensity 
for twelve minutes throughout five regions of interest along the 
abdominal cavity (red rectangles, Figure 6a). When looking at 
the signal of ECFC labeled with MPNH0-COOH, it can be seen 
that the luminescence in the mice does not evolve (Figure 6b) 
and that the luminescence profile traced as indicated above is 
stable after applying the magnet against the right flank of the 
mouse (Figure 6d). On the contrary, when looking at the signal 
of MPNH2-COOH labeled ECFC, we observe a significant pref-
erential accumulation with time of the luminescence situated 
in the right part of the abdomen toward the right flank of the 
mouse, where the magnet is placed (Figure 6c). Moreover, the 
luminescence coming from the left half side of the mice did 
not change over time, unlike that of the right side. The persis-
tent luminescence signal increases significantly in the closest 
area to the magnet (Figure 6e). This graph confirms results 
from the luminescence images: the signal does not evolve at a 
Small 2018, 1800020
Figure 5. Vasculogenesis in vitro with labeled cells on Matrigel. a) Control and MPNH0,1,2,3-COOH (respectively, (b), (c), (d), and (e)) labeled ECFC 
were incubated at 37 °C in EGM-2 during 16 h to form vascular tubes. Properties of the vascular network such as f) the total number of tubes or 
g) the mean tube length were assessed with an online software (Wimasis). Bar graphs represent mean ± SD.
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distance greater than 2 cm from the magnet. This makes it pos-
sible to determine an effective distance of action of the magnet 
on the MPNH2-COOH labeled ECFC. Furthermore, the most 
important evolution of the luminescence takes place during the 
3 or 4 first minutes of the experiment, suggesting that once cell 
sedimentation or tissue adhesion happens, no more cell move-
ment can occur in our experimental conditions.
These first experiments of magnetic cellular vectorization 
using MPNHs in vivo show the possibility to magnetically 
attract MPNH-loaded cells injected into the peritoneal cavity 
and to optically localize them in real time by luminescence 
measurements. This study proved, for the first time, the feasi-
bility of using nanoparticles as a tool to magnetically vectorize 
and concomitantly track cell migration in vivo in real time, 
without unnecessary sacrifice of the animal. The noninvasive 
nature of this technique opens access to information regarding 
cell magnetic vectorization dynamics in living animals. This 
proof of concept was made possible in our situation because it 
was realized on mice. As near-infrared luminescence does not 
have an important penetration depth, its actual potential would 
be limited to preclinical studies on small animals, peroperative 
imaging, and surface applications (dermatology, gastrointes-
tinal endoscopy). Another promising enhancement of this tech-
nique could be achieved using PLNP emitting in the second 
near-infrared window (between 1.0 and 1.4 µm), as penetration 
depth is higher for this wavelength range.
3. Conclusion
Nanoparticles with persistent luminescence and magnetic prop-
erties were integrated into nanohybrids in order to label cells of 
Small 2018, 1800020
Figure 6. In vivo magnetic vectorization of labeled ECFC and real-time optical imaging of their biodistribution. a) Representation of the in vivo 
experiment and segmentation of mice abdomen to follow the evolution of the luminescence distribution. Characteristic evolution of persistent 
luminescence distribution in a mouse after injection of MPNH0-COOH labeled ECFC (b, control experiment) or c) MPNH2-COOH labeled ECFC and 
corresponding graphs (respectively, (d) and (e)). Statistical analyses were realized between the luminescence intensities before and 12 min after magnet 
apposition using an Anova test followed by a Bonferroni comparison. * and *** indicate p < 0.05 and p < 0.001.
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therapeutic interest. In this study, we showed that with such 
MPNHs, it is possible to define nontoxic labeling conditions, 
which allow cells tracking in real time using persistent lumi-
nescence. Moreover, this led to signals devoid of autofluores-
cence and allowed following the injected cells in vivo dynamic 
and attraction with a magnet. Our findings provide a proof of 
concept demonstrating that it is possible to realize real-time 
optical monitoring of magnetically targeted ECFC in vitro and 
in vivo with a good sensitivity using persistent luminescence. 
Thus, we postulate that, by applying an appropriate magnetic 
field gradient, the approach developed in this study could be 
useful to assess cell targeting to specific locations inside the 
body for cell-based therapies. This study also suggests the pos-
sibility to realize cell retention in the peritoneal cavity using our 
nanoparticles, which may be interesting for applications such 
as cancer cell therapies[45] if similar results are further obtained 
with different kind of therapeutic cells.
4. Experimental Section
Chemicals and Biologics: Zinc nitrate hexahydrate (>99%), diglycolic 
anhydride (>90%), and dimethylhydroxylamine solution (40%) were 
obtained from Fluka. Gallium oxide (99.999%), chromium (III) 
nitrate nonahydrate (99.99%), and sodium n-dodecyl sulfate (99%) 
were purchased from Alfa Aesar. Dimethylformamide (>99.99%) was 
purchased from SDS. CTAB (>98%), tetraethyl orthosilicate (TEOS, 
>98%), iron (II) chloride tetrahydrate, caffeic acid, and HCl were 
purchased from Sigma-Aldrich. Water was purified with a Millipore 
system (resistivity 18.2 MΩ cm). HBSS and D-PBS were purchased from 
Dubco.
ECFC Isolation, Culture, and Labeling: Umbilical cord blood collected 
from consenting mothers was diluted in an equal volume of HBSS, 
and mononuclear cells were isolated by density-gradient centrifugation 
using 1.077 g mL−1 Histopaque solution (Sigma Chemicals, Saint 
Quentin Fallavier, France) as described by Bompais et al.[46] CD34+ 
cells were selected with immunomagnetic beads and the MACS 
technique (Miltenyi Biotec, Paris, France). They were plated on 0.2% 
gelatin-coated 24-well plastic culture dishes at a density of 5.105 cells 
per well in endothelial growth medium (EGM-2, Lonza, Walkersville, 
MD, USA). After 4 d, nonadherent cells were removed by thorough 
washing with culture medium. After 10 d of culture, ECFC colonies 
became visible microscopically. Cells were then detached with trypsin-
EDTA (Eurobio, Les Ulis, France) and expanded in EGM-@ on 0.2% 
gelatin coated plates and grown at 37 °C in a humidified 5% CO2 
atmosphere for further use. ECFC were used 25 to 45 d after cord 
blood processing.
Cell labeling was performed by adding a suspension of MPNHs 
in EGM-2 culture medium to adherent cells. Cells were incubated at 
37 °C for different incubation times (6 or 24 h) with various MPNH 
concentrations. Incubation was followed by two washes with MPNH-free 
D-PBS.
Synthesis and Functionalization of the Four Nanohybrids: Persistent 
luminescence nanoparticles (ZnGa2O4:Cr3+), maghemite ultrasmall 
iron oxide nanoparticles (γ-Fe2O3), and the four types of mesoporous 
nanohybrides were synthesized as previously described.[31]
The surface functionalization of MPNHs was realized as follow: 
MPNH0,1,2,3-NH2 nanoparticles were obtained by adding APTES 
(40 µL) to a suspension of MPNH0,1,2,3-OH (10 mg) in DMF 
(4 mL). The reaction mixture was sonicated for the first 2 min using 
a Branson Ultrasonic Cleaner 1210 and kept under vigorous stirring 
for 5 h at room temperature (RT). Particles were washed from the 
unreacted APTES by three centrifugation/redispersion steps in DMF. 
MPNH0,1,2,3-COOH were obtained by having DGA (2.7 mg) reacted 
with MPNH0,1,2,3-NH2 particles (10 mg) in DMF (4 mL) under vigorous 
stirring overnight at RT. After washing, MPNH0,1,2,3-COOH were 
dispersed in sterile glucose (5%).
Alamar Blue Assay: Before realizing this assay, it is necessary to 
determine the linearity range of this test. Growing amounts of cells (nine 
conditions from 4.103 to 2.104 cells per well) were seeded in 96-well flat 
bottom plates (Falcon, Strasbourg, France) and incubated subsequently 
in complete culture medium, without Alamar Blue reagent for 24 h 
and with Alamar Blue for 5 h. Fluorescence measurements were then 
realized every hour (λexc = 530 nm/λem = 590 nm) with a Tecan Infinite 
Pro 2000 (Tecan Trading AG, Switzerland). This experiment allowed us 
to determine efficient conditions for the following cytotoxicity assays.
ECFC were seeded at a density of 104 cells per well in 96-well flat-
bottom plates and incubated in complete culture medium (EGM-2) 
for 24 h. Then, medium was replaced by EGM-2 containing increasing 
concentrations of MPNH-NH2 or MPNH-COOH. After 6 or 24 h, 
medium was removed and EGM-2 with Alamar Blue reagent (10%, v/v) 
was added for 4 h at 37 °C. Cell viability is calculated from the measured 
fluorescence of metabolized Alamar Blue using a Tecan Infinite Pro 2000.
Cell Proliferation Assay: ECFC were seeded at a density of 103 cells 
per well in 96-well flat-bottom plates and incubated in complete 
culture medium overnight. Cells were then exposed 6 h to EGM-2 
(control), MPNH-NH2 or MPNH-COOH suspensions in EGM-2 at the 
concentration of 0.25 mg mL−1. Mediums were then removed and three 
control wells, as well as three MPNH-treated wells, were treated as 
follow: the supernatants were removed, wells were gently washed using 
300 µL of DPBS, cells were treated with 20 µL of trypsin-EDTA for 5 min 
at 37 °C before adding 40 µL of 10% trypan blue (v/v) EGM-2, cells 
were transferred in an Eppendorf tube and another 20 µL of EGM-2 was 
used to rinse the wells. Cells were then counted on a Malassez cell. This 
action was repeated over time.
Magnetophoresis: Cellular uptake was quantified by means of 
magnetophoresis,[47] which consists of measuring the velocity of labeled 
cells in a magnetic field gradient of know cartography (magnetic field 
gradient gradB = 18.5 mT mm−1). The iron mass per cell is calculated 
from the balance of viscous force (6πηRυ, η being the water viscosity, R 
the cell radius, υ the cell velocity) and the magnetic force (M*gradB, M 
being the cell magnetic moment). Measuring, from video analysis, the 
velocity υ and the radius R of cells migrating toward the magnet, their 
magnetic moment or, equivalently, their iron mass mFe were obtained. 
In addition to the mean cellular magnetic load, this assay allows 
determining the iron mass distribution in the cell population (n > 87 
cells for each incubation condition).
Optical Characterization of Cells: Labeled cells were fixed in Eppendorf 
tubes containing a low gelling point agarose (BMA Products, USA) 
solution 3% (w/v) at 38 °C, and a concentration of 1.5.106 ECFC mL−1. 
Eppendorfs were then illuminated for 5 min before signal acquisition. 
Signal acquisition was carried out using a photon-counting system 
based on a cooled GaAs intensified charge-coupled device camera 
(Optima, Biospace, Paris, France).
Magnetic Characterization of Cells: The agarose gels were also used 
to perform MRI measurements. MRI was performed with a dedicated 
small-animal 4.7 Tesla MR system (Biospec 47/40 USR Bruker), using 
a quadrature transmit/receive body coil with a 35 mm inner diameter. 
A 5 mm water reference tube was also inserted. The T2 sequence was 
used with following parameters: TR = 12 s, 100 TE were done from 
9 ms with 9 ms between each, 149 × 85 matrix, 3 slices of 1 mm 
thickness, resolution 235 × 235 µm, and FOV = 3.5 × 2 cm. The T1 
sequence was used with following parameters: TE = 11 s, TR = 10 s/7 
s/4,5 s/3 s/1,5 s/800 ms/400 ms/200 ms/150 ms/100 ms/90 ms, 149 
× 85 matrix, 3 slices of 1 mm thickness, resolution 235 × 235 µm and 
FOV = 3.5 × 2 cm.
Scratch Test: Cell migration assays were performed by plating 3.105 
ECFC on 6-well plates until confluence was reached. Then, the cells were 
treated with 73.5 µg cm−2 (0.25 mg mL−1) of each MPNH-COOH for 6 h. 
Wells were rinsed with PBS and three wounds were realized in each well 
using a P200 pipette tip. PBS supernatants were discarded and EGM-2 
with 2 or 10% of serum was added. Wounds widths were measured 24 h 
after they were realized. The cells were imaged using a Nikon Diaphot 
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inverted contrast microscope. The width of the wounds was quantified 
using ImageJ. Six width measures were performed on three wounds for 
each condition.
In Vitro Tube Formation Assay: These experiments were carried 
out with cells labeled under the same conditions as for the previous 
experiments (MPNH-COOH, 6 h, 73.5 µg cm−2/0.25 mg mL−1). At the 
same time, 48-well plates were coated with 150 µL of growth factor 
reduced Matrigel. Polymerization of Matrigel was realized at 37 °C 
for 1 h. 4.104 control and labeled ECFC were loaded on Matrigel and 
incubated in EGM-2 for 16 h to allow cellular network structures to fully 
develop. Cell structures were imaged using a Nikon Diaphot inverted 
contrast microscope, and networks were characterized with the online 
software Wimasis Image Analysis, using the Wimtube protocol (www.
wimasis.com/en/products/13/WimTube).
In Vivo Cell Imaging and Tracking: Animal studies were conducted in 
agreement with the French guidelines for animal care in compliance 
with procedures approved by the Paris Descartes ethics committee for 
animal research (ref. CEEA34.JS.142.12). Five weeks old female BALB/c 
mice (Janvier, Le Genest St. Isle, France) were anesthetized by oral 
inhalation of isoflurane. A quantity of 5.105 ECFC was labeled with 
either MPNH0-COOH (control) or MPNH2-COOH under previously 
determined conditions (6 h, 73.5 µg cm−2/0.25 mg mL−1). These 
ECFC were dispersed in 100 µL of a 5% sterile D-PBS solution at a 
concentration of 5.106 ECFC mL−1. The suspension of labeled ECFC was 
first excited ex vivo for 5 min under an orange LED before injection in the 
peritoneal cavity of mice. Animals were then placed on their back under 
the photon-counting device, and the signal acquisitions were performed. 
A luminescence image was realized for ten seconds before applying 
a magnet against the right side of the mouse. Luminescence was 
then followed for ten minutes, until its distribution stops evolving. Four 
ring neodymium magnets (outer diameter 19.1 mm, inner diameter 
9.5 mm, height 6.4 mm, strength 75.5 N, Supermagnete, Gottmadingen, 
Germany) were joined to be applied on the side of the mouse.
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